• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/19

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

19 Cards in this Set

  • Front
  • Back
barbiturates
acute effects: relaxtion, euphoria, sense of inhibition, sedaton, sleep
withdrawal:tremors, nasusea, vomiting, intense perspiring, confusion, convulsions, hallucinations, high fevers, increased heart rate -->resembles closely the withdrawal after chronic alcohol abuse.
benziodiazepines
DIAZEpam (valium), cholirDIAZEpoxide, Xanax. more safe than barbiturates- absorbed slowly in blood stream, relaxation effects
Nonbenziodiazepine
Zolpidem (ambiem), EsZopiclone, (lunesta), Buspirone
patterns of inhalant abuse
associated mostly with young. PEER INFLUENCE. prevalant among children in South America (young as 8-9)
Chronic effects of inhalant abuse
restless, irritable, anxious
societal response to inhalant abuse
oil of mustard, national inhalant and poison awareness week
effects of amyl and butyl nitrates
lowers blood pressure, reflexive increase in heart rate, intense vasodilation
Pure Food and Drug Act 1906
purity and consistency, clearly and accurately identified
Federal Food, Drug, Cosmetics act 1938
drug and cosmetics: accurately identified, research studies to demonstrate safety
Dietary Supplements Health Education Act 1994
guidelines for marketing vitamins and herbal preparations
Tobacco Control Act 2009
FDA authority to regulate tobacco product
Phase of Drug Testing
1- experimental drug administered to healthy volunteers to check for side effects
2-experimental drug given to small population of patients who have the condition for which drug is poss. treatment
3- Exp. drug given to large pop. of patients, issues of safety, effectivenes, and dosage levels are finalized
4- possible adverse reactions to drug that is available to public are monitor by prescribing physicians
R&D for new drug
about 70 million per drug, 30 B dollars per year in industry
SSRI
Selective Serotonin Reuptake Inhibitor- group of antidepressants that slow down reuptake of serotonin synapses in brain
Primary Prevention
Targets children before they start using, wide audience of all school chidlren, age at onset for drug taking is cricital: goal to prevent first use
Secondary Prevention
Targets those who are most "at risk" but not neccassarily using, or use is limited; narrow audience more specific goals: goal is to reduce or prevent further use
Tertiary Prevention
Target those who are currently abusing or addicted, smallest target intensive rehab goals: goal is to prevent continued use or relapse
Dual Diagnosis
treatment of both addiction and mental illness
Effective Prevention Models
Peer-refusal skills, anxiety and stress reduction, social skills and personal decision-making